Schedule 13G ownership disclosure
Personalis Inc
Common Stock, $0.0001 par value per share · CUSIP: 71535D106
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Merck & Co., Inc.
Shares: 14,044,943.00 · Class: 16.5%
- Merck Sharp & Dohme LLC
Shares: 14,044,943.00 · Class: 16.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-131061
- Form type
- SCHEDULE 13G
- Filer
- Merck & Co., Inc.
- CIK
- CIK 310158
- Filed
- Dec 23, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13G beneficial ownership